Rapid Plasma Kallikrein Inhibition Following Oral KVD900 is Associated With Early Symptom Relief in Patients With Hereditary Angioedema

Duckworth, E., Feener, E., Yea, C. et al. (3 more authors) (2022) Rapid Plasma Kallikrein Inhibition Following Oral KVD900 is Associated With Early Symptom Relief in Patients With Hereditary Angioedema. In: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2022 AAAAI Annual Meeting, 25-28 Feb 2022, Phoenix, Arizona. Vol. 149 (2). . Article no: AB167, AB167-AB167. ISSN: 0091-6749. EISSN: 1097-6825.

Metadata

Item Type: Conference abstract
Authors/Creators:
  • Duckworth, E.
  • Feener, E.
  • Yea, C.
  • Audhya, P.
  • Hampton, S.
  • Smith, M.
Dates:
  • Published: February 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Inflammatory Arthritis (Leeds)
Date Deposited: 07 Oct 2024 10:32
Last Modified: 05 Mar 2026 12:11
Published Version: https://www.jacionline.org/article/S0091-6749(21)0...
Status: Published
Identification Number: 10.1016/j.jaci.2021.12.553
Open Archives Initiative ID (OAI ID):

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Export

Statistics

View Altmetric information about this item.


CORE (COnnecting REpositories)